The Epigenomics Program was launched to transform the field of epigenetics by: (1) providing the research community with high quality genome-wide maps of selected epigenetic marks in a wide range of primary cell types and tissues for their use in a number of research applications; (2) supporting research projects that examined whether epigenetics plays a role in human health and disease; and (3) developing revolutionary tools and technologies to more easily conduct epigenetics research. A process evaluation was undertaken to inform and assist the program managers in their administration of the Epigenomics Program.
The program is meeting or exceeding the planned targets for the funded projects, demonstrating synergy and achieving the catalyzing effects of large-scale funding. The results and innovations to-date are increasing researchers' abilities to characterize epigenomic changes and to use these results to interpret genome-wide association studies that try to correlate common genetic variants with disease traits. These results suggest that the program will change the way epigenomics research is performed and utilized.
Report Title: NIH Roadmap Epigenomics Program – Phase II Process Evaluation
Agency Sponsor: NIH, National Institutes of Health
Federal Contact: Rosanna Ng, 301-496-5367
Performer: Social and Scientific Systems, Inc.
Record ID: 9858 (November 30, 2011)